Related Experiment Video
Updated: Jan 19, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Behavioral economic demand for medications and its relation to clinical measures in multiple sclerosis
David P Jarmolowicz1, Derek D Reed1, Tadd D Schneider1
1Department of Applied Behavior Science.
Abstract:
Multiple sclerosis (MS) is a neurodegenerative disorder that causes a wide range of symptoms, which, if left untreated, worsen over time. Despite the availability of effective medications, however, many MS patients fail to take their medications. One possibility is that these patients fail to follow through on treatment recommendations because they do not value these treatments-despite their effectiveness. Prior studies have used principles of microeconomic demand to quantify subjects' valuation of commodities such as alcohol and cigarettes. The current study examined MS patients' microeconomic demand for effective treatments. Patients' willingness to purchase this effective medication was well described by behavioral economic models and was significantly related to MS knowledge and select components of adherence determination. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
Related Concept Videos
Drug Therapy
Antianxiety Medications
Measurement of Bioavailability: Pharmacodynamic Methods
Drug Abuse and Addiction: Pharmacological Phenomena
Psychosis: Goals of Pharmacotherapy
Therapeutic Drug Monitoring: Affecting Factors
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

